| Eosinophilic and noneosinophilic asthma TF Carr, AA Zeki, M Kraft American journal of respiratory and critical care medicine 197 (1), 22-37, 2018 | 446 | 2018 |
| The asthma‐COPD overlap syndrome: a common clinical problem in the elderly AA Zeki, M Schivo, A Chan, TE Albertson, S Louie Journal of allergy 2011 (1), 861926, 2011 | 309 | 2011 |
| The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations S Louie, AA Zeki, M Schivo, AL Chan, KY Yoneda, M Avdalovic, ... Expert review of clinical pharmacology 6 (2), 197-219, 2013 | 259 | 2013 |
| Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease B Yeganeh, E Wiechec, SR Ande, P Sharma, AR Moghadam, M Post, ... Pharmacology & therapeutics 143 (1), 87-110, 2014 | 213 | 2014 |
| Pleiotropic effects of statins: A focus on cancer M Ahmadi, S Amiri, S Pecic, F Machaj, J Rosik, MJ Łos, J Alizadeh, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (12), 165968, 2020 | 179 | 2020 |
| Mevalonate cascade inhibition by simvastatin induces the intrinsic apoptosis pathway via depletion of isoprenoids in tumor cells J Alizadeh, AA Zeki, N Mirzaei, S Tewary, A Rezaei Moghadam, ... Scientific reports 7 (1), 44841, 2017 | 155 | 2017 |
| Autophagy and the unfolded protein response promote profibrotic effects of TGF-β1 in human lung fibroblasts S Ghavami, B Yeganeh, AA Zeki, S Shojaei, NJ Kenyon, S Ott, A Samali, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 314 (3 …, 2018 | 152 | 2018 |
| Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond AA Zeki, L Franzi, J Last, NJ Kenyon American journal of respiratory and critical care medicine 180 (8), 731-740, 2009 | 147 | 2009 |
| Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations T Shao, X Shi, S Yang, W Zhang, X Li, J Shu, S Alqalyoobi, AA Zeki, ... Frontiers in immunology 12, 684699, 2021 | 126 | 2021 |
| Autophagy in airway diseases: a new frontier in human asthma? AA Zeki, B Yeganeh, NJ Kenyon, M Post, S Ghavami Allergy 71 (1), 5-14, 2016 | 102 | 2016 |
| Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD) P Upadhyay, CW Wu, A Pham, AA Zeki, CM Royer, UP Kodavanti, ... Journal of Toxicology and Environmental Health, Part B 26 (5), 275-305, 2023 | 100 | 2023 |
| Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? AA Zeki, JM Bratt, M Rabowsky, JA Last, NJ Kenyon Translational Research 156 (6), 335-349, 2010 | 90 | 2010 |
| Targeting cholesterol metabolism in glioblastoma: a new therapeutic approach in cancer therapy L Pirmoradi, N Seyfizadeh, S Ghavami, AA Zeki, S Shojaei Journal of Investigative Medicine 67 (4), 715-719, 2019 | 86 | 2019 |
| Automatic lung segmentation using control feedback system: morphology and texture paradigm NM Noor, JCM Than, OM Rijal, RM Kassim, A Yunus, AA Zeki, M Anzidei, ... Journal of medical systems 39 (3), 22, 2015 | 77 | 2015 |
| Statin use and asthma control in patients with severe asthma AA Zeki, J Oldham, M Wilson, O Fortenko, V Goyal, M Last, A Last, A Patel, ... BMJ open 3 (8), e003314, 2013 | 74 | 2013 |
| Autophagy, apoptosis, the unfolded protein response, and lung function in idiopathic pulmonary fibrosis P Sharma, J Alizadeh, M Juarez, A Samali, AJ Halayko, NJ Kenyon, ... Cells 10 (7), 1642, 2021 | 68 | 2021 |
| The ER stress/UPR axis in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis M Aghaei, S Dastghaib, S Aftabi, MR Aghanoori, J Alizadeh, P Mokarram, ... Life 11 (1), 1, 2020 | 66 | 2020 |
| Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice J Yang, J Bratt, L Franzi, JY Liu, G Zhang, AA Zeki, CFA Vogel, K Williams, ... American journal of respiratory cell and molecular biology 52 (1), 46-55, 2015 | 66 | 2015 |
| The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: an overview of network organization, procedures, and interventions SN Georas, RJ Wright, A Ivanova, E Israel, LM LaVange, P Akuthota, ... Journal of Allergy and Clinical Immunology 149 (2), 488-516. e9, 2022 | 64 | 2022 |
| Competitive metabolism of L-arginine: arginase as a therapeutic target in asthma JM Bratt, AA Zeki, JA Last, NJ Kenyon Journal of Biomedical Research 25 (5), 299-308, 2011 | 61 | 2011 |
Nick KenyonVerified email at ucdavis.edu
